Stock Mumak

Stock Profile

TKMS

TKMS benefits from Europe's rearmament: Record orders and rising margins meet a demanding valuation.

Stock Snapshot

TKMS_Logo
Table HeaderTable Header
CompanyTKMS AG & Co. KGaA
SectorIndustry / Defense / Naval Shipbuilding
ThemeEuropean rearmament, submarines, frigates, naval electronics
Business ModelDefense technology with a focus on military vehicles, weapons and ammunition, air defense systems, and military electronics
ISINDE000TKMS001
Market Capitalizationapprox. €56 billion
UMBRELLA StatusActive

Mumak Score Card

Geopolitics

Industry

Fundamentals

Sentiment

Technical Analysis

Price Performance (12 Months)

Aktuelle Unternehmensmeldungen

Latest Portfolio Updates

Eli Lilly
Company Update

Eli Lilly – Q2 2026 Earnings Update

Eli Lilly grows rapidly in the second quarter of 2026: Revenue rises 48 percent, Mounjaro and Zepbound skyrocket, full-year guidance
Next Update
Bayer
Company Update

Bayer – Q2 2026 Earnings Update

Bayer increases revenue and operating earnings in Q2 2026 and confirms its full-year targets despite legal risks.
Next Update
Johnson & Johnson
Company Update

Bayer – Q2 2026 Earnings Update

Johnson & Johnson impresses with strong Q2 2026 figures, significantly increasing revenue and free cash flow while raising its guidance
Next Update
Company Update

MUMAK SpotLight of the Week: Apple and Amazon Quarterly Review

Apple and Amazon make a statement – strong quarterly results with differing market reactions
Next Update